Paper8099529
Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M and 3 others. Cancer, 1993. Cited by 108 papers, by iCite.
Cite this record
ConductScience Library. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas. Papers, record 8099529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8099529
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Renal Cell | Major topic |
| Carrier Proteins | Major topic |
| DNA Topoisomerases, Type II | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Glutathione Transferase | Major topic |
| Kidney Neoplasms | Major topic |
| Membrane Glycoproteins | Major topic |
| Neoplasm Proteins | Major topic |
| Proto-Oncogene Proteins | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Biomarkers, Tumor | |
| Drug Resistance | |
| ErbB Receptors | |
| Humans | |
| Immunoenzyme Techniques | |
| Protein-Tyrosine Kinases | |
| Proto-Oncogene Mas | |
| Proto-Oncogene Proteins c-fos | |
| Proto-Oncogene Proteins c-myc | |
| Proto-Oncogene Proteins p21(ras) | |
| Erb-b2 Receptor Tyrosine Kinases | |
| Receptors, Cell Surface | |
| Tumor Cells, Cultured |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28326256 | Glutathione-S-transferase-pi (GST-pi) expression in renal cell carcinoma. | J Kidney Cancer VHL | 2015 | https://conductscience.org/library/papers/28326256 | PubMed |
| 25410594 | Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals. | Target Oncol | 2015 | https://conductscience.org/library/papers/25410594 | PubMed |
| 24058374 | Coniferyl Ferulate, a Strong Inhibitor of Glutathione S-Transferase Isolated from Radix Angelicae sinensis, Reverses Multidrug Resistance and Downregulates P-Glycoprotein. | Evid Based Complement Alternat Med | 2013 | https://conductscience.org/library/papers/24058374 | PubMed |
| 23183822 | Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity. | Oncotarget | 2012 | https://conductscience.org/library/papers/23183822 | PubMed |
| 22505981 | Nephrotoxin-induced renal cell injury involving biochemical alterations and its prevention with antioxidant. | J Clin Med Res | 2012 | https://conductscience.org/library/papers/22505981 | PubMed |
| 19424176 | Glutathione S-transferases in kidney and urinary bladder tumors. | Nat Rev Urol | 2009 | https://conductscience.org/library/papers/19424176 | PubMed |
| 19002796 | Role of oxygenation and vascularization in drug resistance. | Cytotechnology | 1998 | https://conductscience.org/library/papers/19002796 | PubMed |
| 17628779 | [Renal cell carcinoma associated proteins. Isolation, cloning and immunogenicity evaluation]. | Urologe A | 2007 | https://conductscience.org/library/papers/17628779 | PubMed |
| 17186190 | [Palliative and supportive therapy in cases of renal cell carcinoma]. | Urologe A | 2007 | https://conductscience.org/library/papers/17186190 | PubMed |
| 17075973 | Development and characterization of multidrug resistant human hepatocarcinoma cell line in nude mice. | World J Gastroenterol | 2006 | https://conductscience.org/library/papers/17075973 | PubMed |
| 16900370 | [Renal cell carcinoma]. | Urologe A | 2006 | https://conductscience.org/library/papers/16900370 | PubMed |
| 15806434 | Immunotherapy in metastatic renal cell carcinoma. | World J Urol | 2005 | https://conductscience.org/library/papers/15806434 | PubMed |
| 14685825 | Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients. | J Hum Genet | 2004 | https://conductscience.org/library/papers/14685825 | PubMed |
| 10761709 | Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells. | Jpn J Cancer Res | 2000 | https://conductscience.org/library/papers/10761709 | PubMed |
| 9547669 | Multiple resistance modulators combined with carboplatin for resistant malignancies: a pilot study. | Invest New Drugs | 1997 | https://conductscience.org/library/papers/9547669 | PubMed |
| 8913832 | Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis. | Invest New Drugs | 1996 | https://conductscience.org/library/papers/8913832 | PubMed |
| 8879260 | Glutathione S-transferase expression in malignant mesothelioma and non-neoplastic mesothelium: an immunohistochemical study. | J Cancer Res Clin Oncol | 1996 | https://conductscience.org/library/papers/8879260 | PubMed |
| 8674274 | Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas. | Clin Exp Metastasis | 1996 | https://conductscience.org/library/papers/8674274 | PubMed |
| 7913670 | Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases. | Clin Exp Metastasis | 1994 | https://conductscience.org/library/papers/7913670 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| FOS | 2353 | PubTator's text mining | https://conductscience.org/library/genes/2353 | NCBI Gene |
| GSTK1 | 373156 | PubTator's text mining | https://conductscience.org/library/genes/373156 | NCBI Gene |
| HRAS | 3265 | PubTator's text mining | https://conductscience.org/library/genes/3265 | NCBI Gene |
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8099529
GET https://conductscience.org/api/papers/v1/8099529/authors